Monthly use of a real-time continuous glucose monitoring system as an educational and motivational tool for poorly controlled type 1 diabetes adolescents

被引:9
|
作者
Glowinska-Olszewska, B. [1 ]
Tobiaszewska, M. [1 ]
Luczynski, W. [1 ]
Bossowski, A. [1 ]
机构
[1] Med Univ Bialystok, Dept Paediat, Div Cardiol, PL-15274 Bialystok, Poland
来源
ADVANCES IN MEDICAL SCIENCES | 2013年 / 58卷 / 02期
关键词
diabetes type 1; adolescents; real-time continuous glucose monitoring; metabolic control; education; IMPROVED GLYCEMIC CONTROL; SENSOR-AUGMENTED PUMP; PEDIATRIC-PATIENTS; PROLONGED USE; CHILDREN; THERAPY; HYPOGLYCEMIA; VARIABILITY; LIFE;
D O I
10.2478/ams-2013-0024
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: Experience with the use of real-time continuous glucose monitoring systems (RT-CGMS) in teenagers with type 1 diabetes mellitus (T1DM) is limited. We aimed to assess the possibility of glycaemic control improvement and to characterize the group of adolescents, who may gain long-term benefits from the use of the RT-CGMS. Methods: Forty T1DM patients, aged 14.6 +/- 2.1 years, with diabetes duration 7.4 +/- 3.6 years and initial HbA(1)c 9.3 +/- 1.5% were recruited. The analysis was based on one-month glucose sensors use, combined with the thorough family support. Patients were analysed in groups according to baseline HbA(1)c: below and above 7.5%, and 10.0%. Comparison between patients with or without improvement in HbA(1)c after 3-month follow-up was also performed. Patients' satisfaction based on the questionnaire was assessed. Results: HbA(1)c level in entire study group decreased after three months, from 9.3 +/- 1.0% to 8.8 +/- 1.6% (P<0.001). In the group with HbA(1)c improvement, reduction was the highest: 9.0 +/- 1.3% vs. 8.0 +/- 1.2% (P<0.001). Only the group with initial HbA(1)c>10% did not achieve significant improvement: 11.2 +/- 0.5% vs. 10.9 +/- 1.1 (P=0.06). In satisfaction questionnaire the lowest scores (negative opinion) were reported by group of patients with initial HbA(1)c above 10%, while the highest scores (positive opinion) were found in the group with improvement of HbA(1)c after 3 month follow-up. Conclusion: Short-term use of CGMS RT, united with satisfaction questionnaire, performed in poorly controlled teenagers with T1DM, can be useful in defining the group of young patients, who can benefit from long-term CGMS RT use in metabolic control improvement.
引用
收藏
页码:344 / 352
页数:9
相关论文
共 50 条
  • [31] Delay discounting and parental monitoring in adolescents with poorly controlled type 1 diabetes
    Amy Hughes Lansing
    Catherine Stanger
    Rebecca Crochiere
    Ann Carracher
    Alan Budney
    Journal of Behavioral Medicine, 2017, 40 : 864 - 874
  • [32] A Multicomponent Motivational Intervention to Improve Adherence Among Adolescents With Poorly Controlled Type 1 Diabetes: A Pilot Study
    Stanger, Catherine
    Ryan, Stacy R.
    Delhey, Leanna M.
    Thrailkill, Kathryn
    Li, Zhongze
    Li, Zhigang
    Budney, Alan J.
    JOURNAL OF PEDIATRIC PSYCHOLOGY, 2013, 38 (06) : 629 - 637
  • [33] Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: Consensus of experts from SFD, EVADIAC and SFE
    Benhamou, P. -Y.
    Catargi, B.
    Delenne, B.
    Guerci, B.
    Hanaire, H.
    Jeandidier, N.
    Leroy, R.
    Meyer, L.
    Penfomis, A.
    Radermecker, R. -P
    Renard, E.
    Baillot-Rudoni, S.
    Riveline, J. -P
    Schaepelynck, P.
    Sola-Gazagnes, A.
    Sulmont, V.
    Tubiana-Rufi, N.
    Durain, D.
    Mantovani, I.
    DIABETES & METABOLISM, 2012, 38 : S67 - S83
  • [34] Use of Continuous Glucose Monitoring in Patients with Type 1 Diabetes
    Ellis, Samuel L.
    Naik, Ramachandra G.
    Gemperline, Kate
    Garg, Satish K.
    CURRENT DIABETES REVIEWS, 2008, 4 (03) : 207 - 217
  • [35] Multicentre, randomised, controlled study of the impact of continuous sub-cutaneous glucose monitoring (GlucoDay®) on glycaemic control in type 1 and type 2 diabetes patients
    Cosson, E.
    Hamo-Tchatchouang, E.
    Dufaitre-Patouraux, L.
    Attali, J. -R.
    Paries, J.
    Schaepelynck-Belicar, P.
    DIABETES & METABOLISM, 2009, 35 (04) : 312 - 318
  • [36] Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes
    Vigersky, Robert A.
    Fonda, Stephanie J.
    Chellappa, Mary
    Walker, M. Susan
    Ehrhardt, Nicole M.
    DIABETES CARE, 2012, 35 (01) : 32 - 38
  • [37] Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK
    Isitt, John J.
    Roze, Stephane
    Sharland, Helen
    Cogswell, Greg
    Alshannaq, Hamza
    Norman, Gregory J.
    Lynch, Peter M.
    DIABETES THERAPY, 2022, 13 (11-12) : 1875 - 1890
  • [38] Patient-Reported Outcomes for an Integrated Real-Time Continuous Glucose Monitoring/Insulin Pump System
    Peyrot, Mark
    Rubin, Richard R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 (01) : 57 - 62
  • [39] Long-term cost-effectiveness of Dexcom G6 real-time continuous glucose monitoring system in people with type 1 diabetes in Australia
    Isitt, J. J.
    Roze, S.
    Tilden, D.
    Arora, N.
    Palmer, A. J.
    Jones, T.
    Rentoul, D.
    Lynch, P.
    DIABETIC MEDICINE, 2022, 39 (07)
  • [40] Real-Time Continuous Glucose Monitoring Significantly Reduces Severe Hypoglycemia in Hypoglycemia-Unaware Patients With Type 1 Diabetes
    Choudhary, Pratik
    Ramasamy, Sharmin
    Green, Louisa
    Gallen, Geraldine
    Pender, Siobhan
    Brackenridge, Anna
    Amiel, Stephanie A.
    Pickup, John C.
    DIABETES CARE, 2013, 36 (12) : 4160 - 4162